butyrylcarnitine has been researched along with Nervous System Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gordon, N | 1 |
Belanger-Quintana, A; Bischoff, C; de la Mota, JL; Ferrer, I; García, MJ; Gregersen, N; Martin-Hernández, E; Martínez Pardo, M; Merinero, B; Pérez-Cerdá, C; Ruiz Sala, P; Ugarte, M; Vianey-Saban, C | 1 |
2 other study(ies) available for butyrylcarnitine and Nervous System Diseases
Article | Year |
---|---|
Acyl-CoA dehydrogenase deficiency: varieties with neurological involvement.
Topics: Acyl-CoA Dehydrogenase; Carnitine; Child; Child, Preschool; Chromosome Aberrations; Developmental Disabilities; Diagnosis, Differential; Electron-Transferring Flavoproteins; Female; Genes, Recessive; Genetic Variation; Humans; Hypoglycemia; Infant; Infant, Newborn; Male; Malonates; Mass Spectrometry; Metabolism, Inborn Errors; Neonatal Screening; Nervous System Diseases; Pregnancy; Prenatal Diagnosis; Prognosis; Succinates; Sudden Infant Death | 2005 |
Persistent increase of plasma butyryl/isobutyrylcarnitine concentrations as marker of SCAD defect and ethylmalonic encephalopathy.
Topics: Brain Diseases; Butyryl-CoA Dehydrogenase; Carnitine; Humans; Malonates; Mitochondrial Proteins; Nervous System Diseases; Nucleocytoplasmic Transport Proteins | 2006 |